Singulair and Suicidal Behavior |
| Published: March 27, 2008, 12:13 pm |
| Tags: medicine medication, suicide, allergy medication, anxiety, depression, drugs, fda, investigation, medication, meds, montelukast, mood changes, patient information, patient safety, safety information, singulair, suicidal, suicidal actions, suicidal behavior, suicidal thought |
|
In a particularly odd link, the FDA is looking into Singulair, the asthma and allergy drug and its correlation with suicidal behavior. I've taken Singulair in the past and not once did it ever occur to me to think about an allergy medication being linked to suicidal behavior. The FDA also says that it could cause mood and behavior changes. The situation that alerted the FDA to this possibility is the story of 15-year-old Cody Miller who killed himself 17 days after switching from allergy medication Allegra to Singulair. Miller's mother, Kate, approached his medication switch with extreme caution and informed herself of the possible side effects: She checked the Merck website and the information sheet she got from the pharmacist on Singulair and found no red flags, so they were stumped when Cody started acting out of character. I have to hand it to Merck: Once the Millers reported Cody's death, they immediately updated Singulair's warnings to include suicidal thoughts and [ Full article ] |
|
|
No Comments...